Stock Quote

BioAdvance's longtime CEO Barbara Schilberg is retiring; successor named

BioAdvance also announced nearly $6.9 million in new investments, and follow-on investments, in more than a dozen life sciences companies.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.